Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Acetylcysteine | hsa00310 | Lysine degradation | 1.53E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Acetylcysteine | hsa00562 | Inositol phosphate metabolism | 2.54E-03 | 4 | P27987, Q13572, Q96PE3, P42338 | ITPKB, ITPK1, INPP4A, PIK3CB | More | | Acetylcysteine | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Acetylcysteine | hsa03040 | Spliceosome | 3.94E-04 | 8 | Q14562, O43143, O60508, P08579, P26368, Q13595, Q01130, O43447 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS2, PPIH | More | | Acetylcysteine | hsa03060 | Protein export | 4.36E-02 | 1 | Q15005 | SPCS2 | More | | Acetylcysteine | hsa03450 | Non-homologous end-joining | 3.29E-02 | 1 | P13010 | XRCC5 | More | | Acetylcysteine | hsa04014 | Ras signaling pathway | 3.62E-02 | 5 | P42338, P49767, P0DP23, P63218, P50151 | PIK3CB, VEGFC, CALM1, GNG5, GNG10 | More | | Acetylcysteine | hsa04020 | Calcium signaling pathway | 5.15E-05 | 8 | P27987, P21796, Q16566, P30679, O15399, P0DP23, P23634, P49767 | ITPKB, VDAC1, CAMK4, GNA15, GRIN2D, CALM1, ATP2B4, VEGFC | More | | Acetylcysteine | hsa04024 | cAMP signaling pathway | 2.46E-03 | 6 | P42338, P0DP23, P23634, Q16566, Q09472, O15399 | PIK3CB, CALM1, ATP2B4, CAMK4, EP300, GRIN2D | More | | Acetylcysteine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Acetylcysteine | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Acetylcysteine | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | | Acetylcysteine | hsa04070 | Phosphatidylinositol signaling system | 1.49E-03 | 5 | P0DP23, P42338, Q96PE3, Q13572, P27987 | CALM1, PIK3CB, INPP4A, ITPK1, ITPKB | More | | Acetylcysteine | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Acetylcysteine | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Acetylcysteine | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Acetylcysteine | hsa04371 | Apelin signaling pathway | 7.45E-03 | 5 | P63218, P50151, Q13485, Q16566, P0DP23 | GNG5, GNG10, SMAD4, CAMK4, CALM1 | More | | Acetylcysteine | hsa04640 | Hematopoietic cell lineage | 2.18E-03 | 9 | P14778, P27930, P11215, P25063, P07766, P01732, P01730, P06127, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD4, CD5, CD7 | More | | Acetylcysteine | hsa04650 | Natural killer cell mediated cytotoxicity | 2.48E-03 | 8 | P19174, P06239, O60880, P20963, P42338, Q13241, P26718, O14931 | PLCG1, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3 | More | | Acetylcysteine | hsa04658 | Th1 and Th2 cell differentiation | 2.21E-04 | 8 | Q04759, P07766, P20963, P19174, P06239, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, TBX21, IL2RB, RUNX3 | More | | Acetylcysteine | hsa04659 | Th17 cell differentiation | 1.25E-03 | 8 | Q04759, P19174, P06239, P14784, P14778, Q9UL17, P07766, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, TBX21, CD3E, CD247 | More | | Acetylcysteine | hsa04660 | T cell receptor signaling pathway | 3.37E-03 | 8 | Q04759, P42338, P19174, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, CD3E, CD247, CD8A, CBLB, LCK | More | | Acetylcysteine | hsa04664 | Fc epsilon RI signaling pathway | 2.32E-02 | 3 | P42338, P07948, P09917 | PIK3CB, LYN, ALOX5 | More | | Acetylcysteine | hsa04666 | Fc gamma R-mediated phagocytosis | 4.10E-02 | 3 | P07948, P42338, P23528 | LYN, PIK3CB, CFL1 | More | | Acetylcysteine | hsa04713 | Circadian entrainment | 8.43E-03 | 4 | O15399, P0DP23, P63218, P50151 | GRIN2D, CALM1, GNG5, GNG10 | More | | Acetylcysteine | hsa04720 | Long-term potentiation | 1.63E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Acetylcysteine | hsa04724 | Glutamatergic synapse | 4.10E-02 | 3 | O15399, P63218, P50151 | GRIN2D, GNG5, GNG10 | More | | Acetylcysteine | hsa04725 | Cholinergic synapse | 5.94E-03 | 4 | P63218, P50151, Q16566, P42338 | GNG5, GNG10, CAMK4, PIK3CB | More | | Acetylcysteine | hsa04726 | Serotonergic synapse | 1.52E-02 | 4 | P63218, P50151, P33260, P09917 | GNG5, GNG10, CYP2C18, ALOX5 | More | | Acetylcysteine | hsa04728 | Dopaminergic synapse | 4.47E-02 | 4 | P63218, P50151, P0DP23, O00327 | GNG5, GNG10, CALM1, ARNTL | More | | Acetylcysteine | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Acetylcysteine | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Acetylcysteine | hsa04925 | Aldosterone synthesis and secretion | 3.14E-02 | 3 | P0DP23, Q16566, P23634 | CALM1, CAMK4, ATP2B4 | More | | Acetylcysteine | hsa04926 | Relaxin signaling pathway | 5.70E-03 | 5 | P42338, P63218, P50151, P49767, P30679 | PIK3CB, GNG5, GNG10, VEGFC, GNA15 | More | | Acetylcysteine | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Acetylcysteine | hsa05017 | Spinocerebellar ataxia | 5.94E-03 | 4 | Q8TB72, O15399, P42338, P21796 | PUM2, GRIN2D, PIK3CB, VDAC1 | More | | Acetylcysteine | hsa05034 | Alcoholism | 3.62E-02 | 5 | O15399, Q16566, P0DP23, P63218, P50151 | GRIN2D, CAMK4, CALM1, GNG5, GNG10 | More | | Acetylcysteine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Acetylcysteine | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Acetylcysteine | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | | Acetylcysteine | hsa05163 | Human cytomegalovirus infection | 4.19E-02 | 5 | P42338, P63218, P50151, P0DP23, P30101 | PIK3CB, GNG5, GNG10, CALM1, PDIA3 | More | | Acetylcysteine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.19E-02 | 5 | P42338, P63218, P50151, P07948, P0DP23 | PIK3CB, GNG5, GNG10, LYN, CALM1 | More | | Acetylcysteine | hsa05170 | Human immunodeficiency virus 1 infection | 3.27E-02 | 6 | P42338, P63218, P50151, P0DP23, P30101, P23528 | PIK3CB, GNG5, GNG10, CALM1, PDIA3, CFL1 | More | | Acetylcysteine | hsa05204 | Chemical carcinogenesis | 4.62E-02 | 2 | P78417, P33260 | GSTO1, CYP2C18 | More | | Acetylcysteine | hsa05214 | Glioma | 2.32E-02 | 3 | P0DP23, Q16566, P42338 | CALM1, CAMK4, PIK3CB | More | | Acetylcysteine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Cysteine | hsa00410 | beta-Alanine metabolism | 4.50E-02 | 1 | Q6ZQY3 | GADL1 | More | | Cysteine | hsa00471 | D-Glutamine and D-glutamate metabolism | 2.28E-02 | 1 | Q7Z3D6 | C14orf159 | More | | Cysteine | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 4.50E-02 | 1 | Q14442 | PIGH | More | | Cysteine | hsa00565 | Ether lipid metabolism | 4.50E-02 | 1 | Q8N661 | TMEM86B | More | | Cysteine | hsa00770 | Pantothenate and CoA biosynthesis | 2.28E-02 | 1 | Q6ZQY3 | GADL1 | More | | Cysteine | hsa04062 | Chemokine signaling pathway | 1.81E-02 | 3 | P10145, P09769, Q13009 | IL8, FGR, TIAM1 | More | | Cysteine | hsa04145 | Phagosome | 4.44E-02 | 3 | P60709, P63261, P30511 | ACTB, ACTG1, HLA-F | More | | Cysteine | hsa04151 | PI3K-Akt signaling pathway | 4.97E-02 | 5 | P23229, P48551, P16871, P15336, Q16513 | ITGA6, IFNAR2, IL7R, ATF2, PKN2 | More | | Cysteine | hsa04217 | Necroptosis | 1.93E-02 | 4 | P48551, P52630, P07384, Q99878 | IFNAR2, STAT2, CAPN1, H2AC14 | More | | Cysteine | hsa04530 | Tight junction | 3.85E-02 | 3 | P60709, P63261, P60660 | ACTB, ACTG1, MYL6 | More | | Cysteine | hsa04621 | NOD-like receptor signaling pathway | 7.28E-03 | 5 | P52630, P48551, P59665, P59666, Q16513 | STAT2, IFNAR2, DEFA1; DEFA1B, DEFA3, PKN2 | More | | Cysteine | hsa04630 | JAK-STAT signaling pathway | 1.44E-02 | 4 | P52630, P48551, P16871, Q06124 | STAT2, IFNAR2, IL7R, PTPN11 | More | | Cysteine | hsa04714 | Thermogenesis | 2.84E-03 | 4 | P15336, P60709, P63261, P36542 | ATF2, ACTB, ACTG1, ATP5C1 | More | | Cysteine | hsa04728 | Dopaminergic synapse | 4.44E-02 | 3 | P14416, P15336, P07101 | DRD2, ATF2, TH | More | | Cysteine | hsa04921 | Oxytocin signaling pathway | 2.81E-02 | 3 | P60660, P60709, P63261 | MYL6, ACTB, ACTG1 | More | | Cysteine | hsa05030 | Cocaine addiction | 1.35E-03 | 3 | P14416, P07101, P15336 | DRD2, TH, ATF2 | More | | Cysteine | hsa05034 | Alcoholism | 2.21E-02 | 4 | P07101, P15336, P14416, Q99878 | TH, ATF2, DRD2, H2AC14 | More | | Cysteine | hsa05100 | Bacterial invasion of epithelial cells | 2.44E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cysteine | hsa05110 | Vibrio cholerae infection | 2.44E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cysteine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 6.89E-03 | 2 | Q99437, P10145 | ATP6V0B, IL8 | More | | Cysteine | hsa05130 | Pathogenic Escherichia coli infection | 2.21E-02 | 4 | P60709, P63261, Q06124, O95487 | ACTB, ACTG1, PTPN11, SEC24B | More | | Cysteine | hsa05135 | Yersinia infection | 2.81E-02 | 3 | P60709, P63261, Q16513 | ACTB, ACTG1, PKN2 | More | | Cysteine | hsa05143 | African trypanosomiasis | 2.44E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Cysteine | hsa05164 | Influenza A | 8.62E-03 | 4 | P48551, P52630, P60709, P63261 | IFNAR2, STAT2, ACTB, ACTG1 | More | | Cysteine | hsa05323 | Rheumatoid arthritis | 4.28E-02 | 2 | Q99437, P10145 | ATP6V0B, IL8 | More | | Cysteine | hsa05410 | Hypertrophic cardiomyopathy | 1.57E-02 | 3 | P23229, P60709, P63261 | ITGA6, ACTB, ACTG1 | More | | Cysteine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 1.24E-02 | 3 | P23229, P60709, P63261 | ITGA6, ACTB, ACTG1 | More | | Cysteine | hsa05414 | Dilated cardiomyopathy | 1.57E-02 | 3 | P23229, P60709, P63261 | ITGA6, ACTB, ACTG1 | More | | Cysteine | hsa05416 | Viral myocarditis | 2.29E-03 | 3 | P30511, P60709, P63261 | HLA-F, ACTB, ACTG1 | More | | |